Cart
sales@molnova.com
Viroallosecurinine
CAS No. 1857-30-3
Viroallosecurinine( (+)-Viroallosecurinine )
Catalog No. M21491 CAS No. 1857-30-3
(+)-Viroallosecurinine is a natural alkaloid with antibacterial activity. It exhibits a MIC of 0.48 μg/mL for Ps. Aeruginosa and Staph. aureus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 486 | Get Quote |
|
| 10MG | 701 | Get Quote |
|
| 25MG | 1062 | Get Quote |
|
| 50MG | 1458 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameViroallosecurinine
-
NoteResearch use only, not for human use.
-
Brief Description(+)-Viroallosecurinine is a natural alkaloid with antibacterial activity. It exhibits a MIC of 0.48 μg/mL for Ps. Aeruginosa and Staph. aureus.
-
Description(+)-Viroallosecurinine is a natural alkaloid with antibacterial activity. It exhibits a MIC of 0.48 μg/mL for Ps. Aeruginosa and Staph. aureus.
-
In Vitro——
-
In Vivo——
-
Synonyms(+)-Viroallosecurinine
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1857-30-3
-
Formula Weight217.26
-
Molecular FormulaC13H15NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1O[C@@](C2)([C@@H](CCCC3)N3[C@H]2C=C2)C2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mensah JL et al. Antibacterial activity of the leaves of Phyllanthus discoideus. J Ethnopharmacol. 1990 Feb;28(1):129-33.
molnova catalog
related products
-
6-Amino-5-azacytidin...
6-Amino-5-azacytidine has an inhibitory of the growth of E. coli.
-
F1063-0967
F1063-0967 is a Dual-specificity phosphatase 26 (DUSP26) inhibitor with an IC50 of 11.62 μM.
-
Caerulomycin A
Caerulomycin A (Cerulomycin; Caerulomycin) is an antifungal compound. Which induces generation of T cells, enhances TGF-β-Smad3 protein signaling via suppressing interferon-γ-induced STAT1 signaling.
